We are live on
!
Find out more
NCM
Neumann Capital Management Portfolio holdings
AUM
$151M
1-Year Est. Return
24.09%
This Fund
S&P 500
This Quarter
Est. Return
+7.95%
1 Year Est. Return
+24.09%
3 Year Est. Return
+79.39%
5 Year Est. Return
+87.97%
10 Year Est. Return
+267.54%
AUM
$172M
AUM Growth
+$10.5M
(+6.5%)
Cap. Flow
-$1.28M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
46.83%
Holding
73
New
1
Increased
18
Reduced
29
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$346K |
| 2 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$259K |
| 3 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$252K |
| 4 |
Pfizer
PFE
|
+$210K |
| 5 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
+$202K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$623K |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$339K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$297K |
| 4 |
Boeing
BA
|
+$278K |
| 5 |
Apple
AAPL
|
+$264K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.57% |
| 2 | Financials | 6.48% |
| 3 | Healthcare | 5.78% |
| 4 | Communication Services | 5.2% |
| 5 | Energy | 2.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.45B
| $10.8M | 6.3% |
184,942
+3,472
| +2% | +$202K |
|
2
iShares Core S&P Small-Cap ETF
IJR
$110B
| $9.89M | 5.74% |
117,904
+379
| +0.3% | +$30.5K |
|
3
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $9.01M | 5.23% |
218,850
+3,540
| +2% | +$140K |
|
4
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.69B
| $8.19M | 4.76% |
171,334
+3,884
| +2% | +$178K |
|
|
5
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $8.15M | 4.73% |
25,319
-965
| -4% | -$297K |
|
6
iShares MSCI EAFE ETF
EFA
$78.5B
| $8.06M | 4.68% |
116,114
+1,523
| +1% | +$103K |
|
7
Vanguard Real Estate ETF
VNQ
$39.4B
| $7.51M | 4.36% |
80,940
+40
| +0% | +$3.7K |
|
|
8
Apple
AAPL
$4.9T
| $7.29M | 4.23% |
99,236
-4,100
| -4% | -$264K |
|
9
State Street SPDR S&P Dividend ETF
SDY
$21.8B
| $6.32M | 3.67% |
58,751
-80
| -0.1% | -$8.4K |
|
|
10
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $5.43M | 3.15% |
61,696
-3,900
| -6% | -$339K |
|
11
Oracle
ORCL
$367B
| $4.94M | 2.87% |
93,264
-1,200
| -1% | -$66.1K |
|
12
WisdomTree International SmallCap Dividend Fund
DLS
$1.06B
| $4.34M | 2.52% |
61,098
-336
| -0.5% | -$22.7K |
|
13
Alphabet (Google) Class A
GOOGL
$4.08T
| $4.19M | 2.43% |
62,600
-600
| -0.9% | -$38.7K |
|
14
Bank of America
BAC
$433B
| $4.07M | 2.36% |
115,475
-1,200
| -1% | -$38.8K |
|
15
CVS Health
CVS
$134B
| $3.21M | 1.86% |
43,153
-1,115
| -3% | -$78.3K |
|
16
NVIDIA
NVDA
$4.72T
| $2.97M | 1.72% |
504,800
-9,000
| -2% | -$46.8K |
|
17
Gilead Sciences
GILD
$163B
| $2.86M | 1.66% |
43,960
-1,400
| -3% | -$91.2K |
|
18
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.7B
| $2.76M | 1.6% |
46,420
-780
| -2% | -$44.7K |
|
19
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.27B
| $2.61M | 1.52% |
27,050
-200
| -0.7% | -$18.5K |
|
20
Verizon
VZ
$193B
| $2.57M | 1.49% |
41,842
+450
| +1% | +$27.1K |
|
21
Vanguard Morningstar Total Stock Market ETF
VTI
$657B
| $2.37M | 1.38% |
14,491
-95
| -0.7% | -$14.9K |
|
22
Allstate
ALL
$68.3B
| $2.34M | 1.36% |
20,780
| – | – |
|
|
23
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.85B
| $2.3M | 1.34% |
26,976
+3,150
| +13% | +$259K |
|
24
JPMorgan Chase
JPM
$933B
| $2.26M | 1.31% |
16,190
-620
| -4% | -$79.5K |
|
25
iShares Core S&P US Growth ETF
IUSG
$31.3B
| $2.2M | 1.28% |
32,486
| – | – |
|
Similar funds
BA
DIG
MCCM
HEC
SHF
CCM
BDS
WBCM
Neumann Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Neumann Capital Management held 73 positions worth $172M, up 6.5% from $162M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Neumann Capital Management's Q4 2019 filing shows 1 new, 18 increased, 29 reduced and 3 closed positions. Its largest new stake was Pfizer: 5,890 shares worth $219K. The largest sale was Celgene Corp, an estimated $623K.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- Neumann Capital Management's largest Q4 2019 buy was Pfizer: 5,890 shares worth $219K.
- Neumann Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $346K increase.
- Neumann Capital Management's biggest Q4 2019 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $339K.
- Neumann Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $623K.
- Neumann Capital Management's ten largest holdings make up 47% of its $172M portfolio in Q4 2019.
- Neumann Capital Management opened 1 new position and closed 3 in Q4 2019.
- Neumann Capital Management's portfolio value rose 6.5% quarter-over-quarter to $172M.
Based on Neumann Capital Management's 13F filing for Q4 2019, filed 24 Jan 2020.